Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | NCF1 | P14598 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CD38 | P28907 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4795307 | 0.82 | MAPT (0.39) | CYP2C19NCF1CYP1A2MAPTCYP2C9 | |
| SCHEMBL4777348 | 0.79 | GBA1 (0.36) | CYP2C19CYP1A2MAPTCYP2C9SMN1; SMN2 | |
| SCHEMBL4774106 | 0.78 | ALDH1A1 (0.44) | CYP2C19CYP1A2MAPTCYP2C9SMN1; SMN2 | |
| SCHEMBL7247349 | 0.77 | CYP1A2 (0.42) | CYP2C19NCF1CYP1A2MAPTCYP2C9 | |
| SCHEMBL4775733 | 0.74 | FES (0.35) | CYP2C19CYP1A2MAPTCYP2C9SMN1; SMN2 | |
| SCHEMBL4610548 | 0.72 | KCNH3 (0.43) | SMN1; SMN2TSHRGBA1HTT | |
| SCHEMBL4767007 | 0.71 | ALDH1A1 (0.47) | SMN1; SMN2TSHRALDH1A1LMNAHTT | |
| SCHEMBL4775196 | 0.71 | ALDH1A1 (0.44) | MAPTTSHRALDH1A1MAPK1LMNA | |
| SCHEMBL4794120 | 0.69 | NCF1 (0.40) | CYP2C19NCF1CYP1A2MAPTCYP2C9 | |
| SCHEMBL6107307 | 0.68 | NAAA (0.47) | MAPTSMN1; SMN2TSHRALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040010007-A1 | Ether substituted imidazopyridines | 3M INNOVATIVE PROPERTIES COMPANY | 2004-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010007-A1 | Ether substituted imidazopyridines | IL2, IL4, MYD88 | CYP2C19 1783/4885NCF1 321/4885CYP1A2 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.